SCHEMBL482706

SCHEMBL482706

C=CC(Br)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17937799 0.75
SCHEMBL8928316 0.75
SCHEMBL11276691 0.72
SCHEMBL11276692 0.72
SCHEMBL11284901 0.71
SCHEMBL4584163 0.69
SCHEMBL7863991 0.69
SCHEMBL4695364 0.69
Propene SCHEMBL28030809 0.69
SCHEMBL11285954 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116693747-B Viscosity-increasing type temperature-resistant salt-tolerant polymer filtrate reducer and preparation method and application thereof 长江大学 2025-02-11 CN claimed
CN-116693747-A Viscosity-increasing type temperature-resistant salt-tolerant polymer filtrate reducer and preparation method and application thereof 长江大学 2023-09-05 CN claimed
WO-2010033598-A2 SYSTEM AND METHOD FOR UTILIZING MICROBUBBLES AND LIPOSOMES AS VIRAL SEQUESTERING AGENTS VERUS BIOTECHNOLOGY CORPORATION (US) 2010-03-25 WO claimed
US-20100069814-A1 SYSTEM AND METHOD FOR UTILIZING MICROBUBBLES AND LIPOSOMES AS VIRAL SEQUESTERING AGENTS VERUS BIOTECHNOLOGY CORPORATION 2010-03-18 US claimed
US-7078015-B2 TEMPERATURE ACTIVATED GASEOUS LIPOSOMES; THERAPY DRUG DELIVERY; ACCUMULATING IN CANCER AND DISEASE TISSUE IMARX THERAPEUTICS, INC. (US) 2006-07-18 US claimed
EP-0740528-A4 GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION IMARX PHARMACEUTICAL CORP (US) 1998-04-01 EP claimed
US-5733572-A Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles IMARX PHARMACEUTICAL CORP. (US) 1998-03-31 US claimed
CN-1137748-A Gas used as local and subcutaneous transmission carrier and microspheres filled with gas precursor IMARX PHARMACEUTICAL CORP (US) 1996-12-11 CN claimed
EP-0740528-A1 GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION IMARX PHARMACEUTICAL CORP. (US) 1996-11-06 EP claimed
CN-1125389-A Methods of preparing gas and gaseous precursor-filled microspheres IMARX PHARMACEUTICAL CORP (US) 1996-06-26 CN claimed
CN-1125393-A Novel therapeutic delivery systems IMARX PHARMACEUTICAL CORP (US) 1996-06-26 CN claimed
WO-1995015118-A1 GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION IMARX PHARMACEUTICAL CORP. (US) 1995-06-08 WO claimed
EP-0006089-B1 PREPARATION OF IMPACT RESISTANT POLYSTYRENE HAVING IMPROVED TRANSPARENCY THE DOW CHEMICAL COMPANY (US) 1983-03-02 EP claimed
EP-0006089-A1 Preparation of impact resistant polystyrene having improved transparency THE DOW CHEMICAL COMPANY (US) 1980-01-09 EP claimed
US-4100227-A Transparent impact-resistant polystyrene structure THE DOW CHEMICAL COMPANY (US) 1978-07-11 US claimed
CN-116693747-B Viscosity-increasing type temperature-resistant salt-tolerant polymer filtrate reducer and preparation method and application thereof 长江大学 2025-02-11 CN disclosed
EP-2766001-B1 BUFFERED OXYGEN THERAPEUTIC NUVOX PHARMA LLC (US) 2024-05-15 EP disclosed
EP-0000555-A1 Process for the preparation of oxiranes substituted by halogen alkyl BAYER AG (DE) 1979-02-07 EP disclosed
US-4100228-A Transparent impact styrene polymer structure THE DOW CHEMICAL COMPANY (US) 1978-07-11 US disclosed
US-4100227-A Transparent impact-resistant polystyrene structure THE DOW CHEMICAL COMPANY (US) 1978-07-11 US disclosed